Strategies to Prevent Anthracycline-Related Congestive Heart Failure in Survivors of Childhood Cancer
Cardiovascular complications are a leading cause of therapy-related morbidity and mortality in long-term survivors of childhood malignancy. In fact, childhood cancer survivors are at a 15-fold risk of developing CHF compared to age-matched controls. There is a strong dose-dependent association betwe...
Saved in:
| Main Authors: | Saro H. Armenian, Sarah K. Gelehrter, Eric J. Chow |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2012-01-01
|
| Series: | Cardiology Research and Practice |
| Online Access: | http://dx.doi.org/10.1155/2012/713294 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Congestive heart failure in three dogs
by: Mahmut Ok, et al. -
Natural strategies of preventing anthracycline-induced cardiotoxicity – a review
by: Anca STOICA, et al.
Published: (2022-12-01) -
Pregnancy associated cardiomyopathy in 2 cancer survivors with history of anthracycline use
by: Ramy Zughul, et al.
Published: (2025-06-01) -
The Kidney in Heart Failure: The Role of Venous Congestion
by: Alvaro Tamayo-Gutierrez, et al.
Published: (2022-09-01) -
Lifestyle and Pharmacological Interventions to Prevent Anthracycline-Related Cardiotoxicity in Cancer Patients
by: Luigi Spadafora, et al.
Published: (2025-06-01)